サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1650698

静脈内注射液の世界市場

Intravenous (IV) Solutions

出版日
ページ情報
英文 487 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
静脈内注射液の世界市場
出版日: 2025年02月06日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 487 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

静脈内注射液の世界市場は2030年までに217億米ドルに到達

2024年に141億米ドルと推定される静脈内注射液の世界市場は、2024～2030年の分析期間でCAGR 7.5%で成長し、2030年には217億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである非経口栄養剤は、CAGR 7.9％を記録し、分析期間終了時には151億米ドルに達すると予測されます。末梢非経口栄養セグメントの成長率は、分析期間中CAGR 6.7％と推定されます。

米国市場は55億米ドルと推定、中国はCAGR9.0％で成長予測

米国の静脈内注射液市場は2024年に55億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに22億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.4%と7.2%と予測されています。欧州では、ドイツがCAGR約7.5%で成長すると予測されています。

世界の静脈内注射液市場- 主要動向と促進要因まとめ

静脈内注射液は現代医療の要であり、体液、薬物、栄養素を血流に直接送り込む方法を提供します。これらの輸液は、体液バランス、電解質レベルの維持、経口摂取が不可能または不十分な状況下での薬剤や必須栄養素の供給に極めて重要です。輸液は、その組成と目的に基づいて、晶質液、コロイド液、血液製剤、栄養液などに分類されます。生理食塩水や乳酸リンゲル液などの晶質液は、体液の蘇生や維持に最もよく使用されます。アルブミンやデキストランなどのコロイドは、体液量の拡張に使用されます。非経口栄養を必要とする患者には、炭水化物、タンパク質および脂肪を供給する栄養液が不可欠です。これらの溶液の正確な組成と投与は、患者の特定のニーズに合わせて調整されるため、救急医療から慢性疾患の管理に至るまで、さまざまな医療現場で欠かせないものとなっています。

静脈内注射液市場の成長は、いくつかの要因によって牽引されています。糖尿病、がん、胃腸障害などの慢性疾患の有病率の増加により、これらの疾患の管理に不可欠な輸液療法の需要が高まっています。高齢化社会は脱水や栄養不足に陥りやすく、高齢患者が水分補給や栄養補給のために輸液を頻繁に必要とするため、市場はさらに拡大しています。さらに、外科手術や救急医療の増加により、周術期治療や急性期治療用の信頼性の高い輸液供給が必要となっています。点滴機器の技術的進歩や特殊製剤の開発により、さまざまな臨床現場での点滴療法の利用が拡大しています。さらに、在宅医療や外来診療への注目の高まりにより、携帯可能で投与が容易な輸液製剤の需要が高まり、患者の治療レジメンに柔軟性と利便性がもたらされています。これらの要因が総合的に、ヘルスケア業界における輸液ソリューション市場の堅調な拡大と重要性を裏付けています。

技術の進歩と厳格な品質基準により、輸液の安全性と有効性は大幅に向上しています。最新の点滴療法には、無菌方法の改善、汚染を防ぐための先進パッケージング、調製ミスを最小限に抑えるための混合済み溶液の開発などの進歩が取り入れられています。スマート輸液ポンプのような技術革新は輸液投与に革命をもたらし、輸液速度や輸液量を正確にコントロールできるようになったため、過剰輸液や過少輸液のリスクが減少しました。さらに、電子カルテ（EHR）と輸液システムの統合により、点滴治療の正確な記録とモニタリングが可能になり、患者の安全性が向上しました。製薬業界は、複雑な病態に対応する新しい製剤や輸液ソリューションの組み合わせの開発による技術革新を続け、患者の転帰を改善し、輸液療法の治療用途を拡大しています。

セグメント

タイプ（非経口栄養剤、末梢非経口栄養剤）;栄養剤（単回投与アミノ酸、ビタミン・ミネラル、炭水化物、非経口脂質エマルジョン、その他の栄養剤）

調査対象企業の例（注目の82社）

  • Amanta Healthcare Ltd.
  • Anhui Medipharm Co., Ltd.
  • AxaParenterals Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Fresenius Kabi AG
  • Grifols, S.A.
  • ICU Medical, Inc.
  • JW Life Science
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Salius Pharma Private Limited.
  • Vifor Pharma Management Ltd.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP22111

Global Intravenous (IV) Solutions Market to Reach US$21.7 Billion by 2030

The global market for Intravenous (IV) Solutions estimated at US$14.1 Billion in the year 2024, is expected to reach US$21.7 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Parenteral Nutrition, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$15.1 Billion by the end of the analysis period. Growth in the Peripheral Parenteral Nutrition segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.5 Billion While China is Forecast to Grow at 9.0% CAGR

The Intravenous (IV) Solutions market in the U.S. is estimated at US$5.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.4% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Global Intravenous (IV) Solutions Market - Key Trends & Drivers Summarized

Intravenous (IV) solutions are a cornerstone of modern medical treatment, providing a direct method of delivering fluids, medications, and nutrients into the bloodstream. These solutions are crucial for maintaining fluid balance, electrolyte levels, and for delivering drugs and essential nutrients in situations where oral intake is not possible or insufficient. IV solutions are categorized based on their composition and purpose, such as crystalloids, colloids, blood products, and nutrient solutions. Crystalloids, like saline and lactated Ringer's, are the most commonly used for fluid resuscitation and maintenance. Colloids, including albumin and dextran, are used for volume expansion. Nutrient solutions, which provide carbohydrates, proteins, and fats, are vital for patients requiring parenteral nutrition. The precise composition and administration of these solutions are tailored to meet the specific needs of patients, making them indispensable in various medical settings, from emergency care to chronic disease management.

The growth in the intravenous (IV) solutions market is driven by several factors. The increasing prevalence of chronic diseases such as diabetes, cancer, and gastrointestinal disorders has heightened the demand for IV therapy, which is often essential for managing these conditions. The aging population, with its higher susceptibility to dehydration and nutrient deficiencies, further propels the market, as elderly patients frequently require IV solutions for hydration and nutritional support. Additionally, the rise in surgical procedures and emergency care incidences necessitates a reliable supply of IV solutions for perioperative care and acute treatment. Technological advancements in IV equipment and the development of specialized formulations have expanded the use of IV therapy in various clinical settings. Moreover, the growing focus on home healthcare and outpatient services has increased the demand for portable and easy-to-administer IV solutions, providing patients with greater flexibility and convenience in their treatment regimens. These factors collectively underscore the robust expansion and critical importance of the IV solutions market in the healthcare industry.

Technological advancements and rigorous quality standards have significantly improved the safety and efficacy of IV solutions. Modern IV therapy incorporates advancements such as improved sterility practices, enhanced packaging to prevent contamination, and the development of pre-mixed solutions to minimize preparation errors. Innovations like smart infusion pumps have revolutionized the administration of IV solutions, allowing for precise control over infusion rates and volumes, reducing the risk of over-infusion or under-infusion. Additionally, the integration of electronic health records (EHR) with infusion systems ensures accurate documentation and monitoring of IV therapy, enhancing patient safety. The pharmaceutical industry continues to innovate by developing new formulations and combinations of IV solutions to address complex medical conditions, improving patient outcomes and expanding the therapeutic applications of IV therapy.

SCOPE OF STUDY:

The report analyzes the Intravenous (IV) Solutions market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Parenteral Nutrition, Peripheral Parenteral Nutrition); Nutrient (Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion, Other Nutrients)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 82 Featured) -

  • Amanta Healthcare Ltd.
  • Anhui Medipharm Co., Ltd.
  • AxaParenterals Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Fresenius Kabi AG
  • Grifols, S.A.
  • ICU Medical, Inc.
  • JW Life Science
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Salius Pharma Private Limited.
  • Vifor Pharma Management Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Economic Update
    • Competition
    • Intravenous (IV) Solutions - Global Key Competitors Percentage Market Share in 2024 (E)
    • An Introduction to Intravenous (IV) Solutions
    • Types of Intravenous Solutions
    • Global Market Prospects & Outlook
    • TPN Emerges as the Largest Segment in the IV Solutions Market
    • Single Dose Amino Acid Solutions: The Major Nutrient Type
    • Developed Economies Lead, Developing Regions to Propel Future Growth
    • World Brands
    • Recent Market Activity
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Prominent Trends to Watch-For in Intravenous Solutions Arena
    • Intravenous Therapy Faces Supply Shortages in the US
    • Sudden Shortage of Sodium Chloride Solutions from COVID
    • Medical Plastic Shortages Add to the Supply Woes
    • Resources for Healthcare Providers
    • Aging Global Demography and Resultant Rise in Need for Nutrition Management Augurs Well for the Market Growth
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Growing Prevalence of Malnutrition in Hospitalized Patients to Fuel Need for IV Solutions
    • Daily Requirements for Adults (Male and Female) by Nutrient Type
    • Energy Requirements by Age and Gender
    • Intravenous Fluids: The Lifeblood of Modern Healthcare
    • Rising Prevalence of Chronic Diseases and Resultant Need for Additional Nutrition Enhances Need to Administer IV Solutions
    • Rising Cancer Incidence and Need for Nutritional Support
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Number of New Cancer Cases and Deaths (in Million) by Region for 2020
    • Alarming Rise in Diabetes Incidence Worldwide
    • World Diabetes and Population Statistics (2019, 2030 & 2045)
    • World Diabetes Prevalence (2000-2045)
    • Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045
    • Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
    • Unrelenting Threat of HIV/AIDS Infection
    • Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2020
    • Number of AIDS-Related Deaths (in Thousands) by Region for 2018
    • Nutritional Management of Patients with Neurological Diseases
    • Burden of Neurological Diseases: Deaths Per 100,000 Population due to Neurological Conditions in Select Countries
    • Concerns over Fluid Depletion from Body Due to GI & Diarrheal Diseases Necessitate IV Fluid Administration
    • Growing Numbers of Pre-term Births Drives Demand for IV Solutions
    • Top Countries Ranked by Most Number of Preterm Births
    • Countries with Highest Preterm Birth Rates: Number of Preterm Births Per 100 Live Births by Top Countries
    • Demand Rises for Home Intravenous Nutritional Therapies
    • Premixed IV Nutrition: A Step towards Safer Medication Practices
    • Premixed Formulations Present Efficient Delivery System
    • Iron Replacement Therapies: Potential for Growth
    • Growing Demand for Low-Cost Intravenous Nutrition Solutions
    • Increasing Healthcare Expenditure Creates Conducive Environment
    • World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 & 2023
    • Challenges Confronting IV Solutions Market
    • Issues with Traditional IV Tubing
    • Multi-Lumen IV Tubing to the Rescue
    • Innovative Multi-Lumen Tubing to Rethink IV Administration & Patient Experience
    • The Future of Smart Infusion Pumps for Intravenous Therapy Looks Bright
    • IV Solutions for Hypernatremia
    • Albumin (Human) Injection for Hypovolemia Treatment
    • Rising Focus on Blow-Fill-Seal Technology
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intravenous (IV) Solutions Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intravenous (IV) Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Peripheral Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Peripheral Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Peripheral Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Single Dose Amino Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Single Dose Amino Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Single Dose Amino Acids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Vitamins & Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Vitamins & Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Vitamins & Minerals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Carbohydrates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Parenteral Lipid Emulsion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Parenteral Lipid Emulsion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Parenteral Lipid Emulsion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Nutrients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Nutrients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Nutrients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • JAPAN
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • CHINA
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • EUROPE
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Intravenous (IV) Solutions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • FRANCE
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • GERMANY
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Intravenous (IV) Solutions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • INDIA
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Intravenous (IV) Solutions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Intravenous (IV) Solutions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030
  • AFRICA
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2015, 2025 & 2030

IV. COMPETITION